Sequenom Shares Rise Sharply on Qiagen Pact | GenomeWeb
Shares in Sequenom gained more than 16 percent for the 5-day trading period ended Tuesday. The firm’s shares rose after news on Monday that it had signed a pact with Qiagen under which the firms will collaborate on developing prenatal diagnostics (see related article).
Cepheid led decliners for the week with a 7.65 percent drop, despite no new news regarding the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.